Vera Therapeutics Inc - Ordinary Shares - Class A

NASDAQ:VERA   3:59:53 PM EDT
28.19
-5.09 (-15.29%)
Earnings Announcements

Vera Therapeutics Reports Third Quarter 2021 Financial Results

Published: 11/10/2021 12:23 GMT
Vera Therapeutics Inc - Ordinary Shares - Class A (VERA) - Vera Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update.
Q3 Loss per Share $0.36.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.70

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.80

More details on our Analysts Page.